- Idiopathic pulmonary fibrosis. Can we always diagnose and treat it right?2017 | First Faculty of Medicine
- Referring Czech patients with idiopathic pulmonary fibrosis to a transplant center – data from the EMPIRE registry2023 | First Faculty of Medicine, Second Faculty of Medicine
- The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone2022 | First Faculty of Medicine
- Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIRE2020 | First Faculty of Medicine
- Differences in Baseline Characteristics and Access to Treatment of Newly Diagnosed Patients With IPF in the EMPIRE Countries2021 | First Faculty of Medicine